XML 15 R4.htm IDEA: XBRL DOCUMENT v3.10.0.1
UTAH MEDICAL PRODUCTS, INC. CONSOLIDATED STATEMENT OF INCOME AND COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Jun. 30, 2018
Jun. 30, 2017
Income Statement        
Sales, net $ 10,965 $ 10,829 $ 21,852 $ 21,088
Cost of goods sold 3,981 3,936 7,946 7,660
Gross profit 6,984 6,893 13,906 13,428
Operating expense:        
Selling, general and administrative 1,811 1,740 3,649 3,432
Research and development 117 119 230 238
Total operating expenses 1,928 1,859 3,879 3,670
Operating income 5,056 5,034 10,027 9,758
Other income (expense) 500 23 538 49
Income before provision for income taxes 5,556 5,057 10,565 9,807
Provision for income taxes 1,248 1,187 2,165 2,402
Net income $ 4,308 $ 3,870 $ 8,400 $ 7,405
Earnings per common share (basic) $ 1.15 $ 1.04 $ 2.25 $ 1.99
Earnings per common share (diluted) $ 1.15 $ 1.04 $ 2.24 $ 1.98
Shares outstanding (basic) 3,731 3,716 3,728 3,715
Shares outstanding (diluted) 3,754 3,732 3,751 3,732
Other comprehensive income (loss):        
Foreign currency translation net of taxes of $0 in all periods $ (2,836) $ 1,680 $ (1,535) $ 2,336
Total comprehensive income $ 1,472 $ 5,550 $ 6,865 $ 9,741